Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anatomical and functional retinal changes in multiple sclerosis.
Towards a predictive model for Guillain-Barré syndrome.
HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population.
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
Epstein-Barr virus infection-Related hemophagocytic lymphohistiocytosis.
Measurement characteristics and clinical utility of the 29-item Multiple Sclerosis Impact Scale.
MS patients must have access to the best treatment options.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis.
Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.
The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study.
The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
Isolated dysphagia due to aquaporin-4 autoimmunity.
Current topics in therapeutic plasmapheresis.
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Why this is not multiple sclerosis: a case based approach.
Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition.
Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.
Multiple Sclerosis and Experimental Allergic Encephalomyelitis.
Pages
« first
‹ previous
…
578
579
580
581
582
583
584
585
586
…
next ›
last »